ETFMG Alternative Harvest ETF

Most Recent

  • uploads///EBITDA Margin FY  Estimates
    Company & Industry Overviews

    What Analysts Estimate for Cannabis Companies’ Earnings Margins

    Let’s now look at how capacity expansion could translate into cannabis companies’ margins.

    By Adam Jones
  • uploads///Forecast
    Consumer

    Considerations for Investors in Marijuana or Cryptocurrencies

    The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.

    By Adam Jones
  • uploads///Top Holdings
    Company & Industry Overviews

    A Look at 2 New Marijuana ETFs that Debuted Last Week

    While marijuana stocks (MJX) ended in the negative territory week-over-week last week, two new marijuana sector-specific ETFs debuted.

    By Adam Jones
  • uploads///Gross Margins
    Earnings Report

    How Canopy Growth’s Margins Looked in 3Q18

    During 3Q18, Canopy Growth reported a non-GAAP (generally accepted accounting principles) gross margin of 58% of sales.

    By Adam Jones
  • uploads///Scotts Miracle Gro Adjusted EPS and Stock Price
    Basic Materials

    Why Scotts Miracle-Gro Stock Fell 14% on January 30

    On Tuesday, January 30, 2018, Scotts Miracle-Gro (SMG) reported its 1Q18 earnings with a GAAP loss per share of $0.35. The stock took a significant beating and fell 14%.

    By Adam Jones
  • uploads///Chart Title
    Company & Industry Overviews

    Canopy Growth’s Recreational Marijuana Sales Channel

    Canopy Growth stated that the Canadian provinces of Ontario and New Brunswick announced that the retail and distribution of recreational marijuana would be overseen by their liquor control boards.

    By Adam Jones
  • uploads///Cryptocurrency versus Marijuana
    Consumer

    Why the Marijuana Wave May Not Be the Same as Cryptocurrency

    In 2018, two investment waves set the market ablaze—marijuana and cryptocurrencies. Although cryptocurrencies have slid since early January, the marijuana wave has held up so far.

    By Adam Jones
  • uploads///Market Reach
    Miscellaneous

    Aurora Cannabis’s Reach and the CanniMed Acquisition

    In our series Must-Knows before Investing in the Marijuana Industry, we saw how, globally, the acceptance of marijuana has evolved, with more countries either legalizing cannabis access at a federal level or exploring the possibility of legalizing cannabis.

    By Adam Jones
  • uploads///CanniMed Stock Pops on Acquisition Announcement
    Miscellaneous

    Aurora Cannabis Acquires CanniMed Therapeutics

    The marijuana space is already heating up with mergers and acquisitions ahead of recreational marijuana legalization expected in Canada later this year.

    By Adam Jones
  • uploads///Canaccord
    Miscellaneous

    Who Will Be the Biggest Players in the Marijuana Space?

    With the marijuana sector heating up in Canada lately, we know that several existing and new companies will be rushing to capitalize on the opportunity.

    By Adam Jones
  • uploads///Marijuana ETF Performance
    Consumer

    How Wall Street Is Taking an Interest in the Marijuana Industry

    Marijuana is still classified as a Schedule 1 drug in the United States and is illicit under federal law. This has created several issues for businesses.

    By Adam Jones
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.